Juvisync and Breastfeeding

The manufacturer of Juvisync (sitagliptin/simvastatin) recommends that women not use this drug while nursing, as it is unknown whether the medicine passes through human breast milk or if it would harm a nursing infant. Because this drug could affect blood sugar and cholesterol levels in a nursing infant, women should not use Juvisync while breastfeeding without first talking to their doctor.

In September 2013, Merck & Co, Inc., announced that it would be discontinuing this medication. It is clear that this decision was made for business reasons, not for safety reasons.

Can Breastfeeding Women Take Juvisync?

It is unknown if Juvisync^® (sitagliptin/simvastatin) is safe for use while nursing. Currently, it is recommended that women should not take this product while breastfeeding. Therefore, you should talk with your healthcare provider before taking this medicine if you are breastfeeding or plan to start.

More Information on Juvisync and Breastfeeding

It is not known whether either of the active ingredients in Juvisync (simvastatin and sitagliptin) passes through breast milk in humans. It is also unclear whether Juvisync would cause significant problems in a nursing infant.

Because of the way it works, Juvisync might affect blood sugar levels and cholesterol levels in a breastfeeding infant, potentially causing serious problems. If the drug does happen to pass through breast milk, it is also thought that an infant would likely develop any of the possible Juvisync side effects.

Talking With Your Healthcare Provider

You should discuss breastfeeding and Juvisync use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.